{"disease":{"id":"glomerulonephritis-membranous","name":"glomerulonephritis membranous"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT05656963","title":"The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD","phase":"","overall_status":"UNKNOWN","enrollment_count":741,"lead_sponsor_name":"Yipeng Liu","has_results":false},{"nct_id":"NCT05914155","title":"Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Shoichi Maruyama MD PhD","has_results":false},{"nct_id":"NCT05797051","title":"Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT03880643","title":"Rituximab in Refractory Primary Membranous Nephropathy","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT04145440","title":"Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"HI-Bio, A Biogen Company","has_results":true},{"nct_id":"NCT04733040","title":"Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"HI-Bio, A Biogen Company","has_results":false},{"nct_id":"NCT01610492","title":"A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00050713","title":"Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}